This event organized by the DMCCB, will feature six national and international speakers talking about «Targeting RNA by Small Molecules», a topic selected by the DMCCB members.
The programme includes talks from:
- Kamal Azzaoui, Saverna Therapeutics, Basel, Switzerland
- Michaela Frye, Deutsches Krebsforschungszentrum, Heidelberg, Germany
- Amanda E. Hargrove, Duke University, Durham, United States
- Iris Alroy, Anima Biotech, Bernardsville, United States
- Matthew Disney, Scripps Research Institute, United States
- tbd, Storm Therapeutics, Cambridge, United Kingdom
Attendees will have the possibility to present their work during the poster session in the form of short video presentations.
The goal of the symposium is to share cutting-edge scientific results and stimulate a stronger cooperation among persons working in different areas of medicinal chemistry and chemical biology. This event is directed towards scientists from industry and academia, as well as students interested in medicinal chemistry and chemical biology.
Deadline for poster submission is January 13, 2021.
For more information please contact: email@example.com
This meeting brings together about 250 young European scientists and gives them the opportunity to present their most recent results. The topics presented cover all aspects of medicinal chemistry: chemical biology, chemoinformatics, SAR studies, ADMET, imaging, physical chemistry, biolabeling and diagnostic tools, drug vectorization, nanotechnologies, natural products, synthetic methodology, etc…
Deadline for registration: December 20, 2020
For more information please contact: firstname.lastname@example.org
- Société de Chimie Thérapeutique (SCT) (France)
The key role of G protein-coupled receptors (GPCRs) in human disease underpins their importance to modern medicine. We are pleased to be holding this 7½th interim meeting in the series on GPCR drug discovery, which will combine cutting edge medicinal chemistry with innovative structural biology and novel drug design approaches.
For more information please contact: email@example.com
- The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)
18th Hellenic Symposium on Medicinal Chemistry
EFMC Sponsored Event
18th Hellenic Symposium on Medicinal Chemistry (HSMC-18) is organized by the Hellenic Society of Medicinal Chemistry (HSMC).
It continues the tradition of biannual meetings established since 35 years in Greece as a forum for the discussion of recent advances in medicinal chemistry. The topics include drug design and lead identification and optimization, protein-protein interactions and protein degradation, ADME/Tox properties, advances in Synthetic Medicinal Chemistry, Natural Products, Pharmacology as well as the impact of artificial intelligence in the integration of data- intensive practices to Drug Discovery.
Under this multidisciplinary research umbrella the major therapeutic areas, such as treatment of inflammatory diseases, infectious diseases, metabolic disorders, cardiovascular diseases, neurodegenerative diseases and oncology will be discussed. Sections on Pharmaceutical Analysis will be integrated in the symposium program.
Deadline for Oral Communication submission: January 29, 2021
Deadline for Poster Presentation submission: February 5, 2021
For more information please contact: firstname.lastname@example.org
- Hellenic Society of Medicinal Chemistry (Greece)